Posted 17 June, 2021
Verve Therapeutics, Inc. IPO completed
IPO completed detected for ticker Nasdaq:VERV in a 424B4 filed on 17 June, 2021.
This is an initial public offering of shares of common stock by Verve Therapeutics, Inc.
Don't know how to trade IPO completion? Read Initial Public Offerings.
Overview of Verve Therapeutics, Inc.
Health Care/Life Sciences • Biotechnology
Verve Therapeutics, Inc. is a genetic medicines company, which engages in the development of approach to the care of cardiovascular diseases. The company was founded by Sekar Kathiresan, Kiran Musunuru, Keith J. Joung, Issi Rozen, Sekar Kathiresan, Burt A. Adelman and Barry Ticho in 2018 and is headquartered in Boston, MA.Market Cap
$1.24B
View Company Details
$1.24B
Interested in special situations?
Join Tickerverse
- customize event filters
- create watchlists, bookmarks
- get email notifications for the latest special situations
- browse and analyze public companies, executives and SEC filings
Tickerverse is a great way to find investment opportunities in corporate actions.
By signing up you agree to our Terms of Service and Privacy Policy.